{"id":"W4241108392","doi":"10.1093/eurheartj/ehz748.0099","title":"2180Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Aspirin; Rivaroxaban; Hazard ratio; Myocardial infarction; Atrial fibrillation; Internal medicine; Population; Stroke (engine); Warfarin; Diabetes mellitus; Cohort; Cardiology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007364131,0.001109343,0.001552376,0.0003955369,0.0002720013,0.001580324,0.000881161,0.0008567248,0.002358242],"category_scores_gemma":[0.006751989,0.0003438216,0.003812884,0.0006697729,0.0004509497,0.0007394105,0.0008264356,0.001129871,0.0003845012],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004397461,"about_ca_system_score_gemma":0.0005804232,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001700242,"about_ca_topic_score_gemma":0.001614937,"domain_scores_codex":[0.9979045,0.001208559,0.0001486249,0.0003933775,0.0002543782,0.00009065233],"domain_scores_gemma":[0.9934672,0.002753647,0.001720815,0.001093137,0.0004119601,0.0005534277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3695642,0.001444274,0.5619993,0.0008640585,0.032933,0.0001627772,0.0001873381,0.006794846,0.001016671,0.0005072698,0.003685268,0.02084091],"study_design_scores_gemma":[0.08962548,0.03585383,0.8089199,0.0002667017,0.02910098,0.000438883,0.0002743784,0.02583926,0.001421974,0.002336529,0.005710662,0.0002115054],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991775,0.001850043,0.000729799,0.0002038152,0.00006863091,0.0001788316,0.003606973,0.00003417964,0.001552749],"genre_scores_gemma":[0.9910402,0.0004083063,0.0005580321,0.0001947317,0.0001485184,0.0002231116,0.006826522,0.00001439827,0.0005862323],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007364131,"threshold_uncertainty_score":0.03894567,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02424362611325016,"score_gpt":0.2476501920474274,"score_spread":0.2234065659341773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}